Early administration of Wumei Wan inhibit myeloid-derived suppressor cells via PI3K/Akt pathway and amino acids metabolism to prevent colitis-associated colorectal cancer.

MLA

Lu, Zhi-Hua, et al. “Early Administration of Wumei Wan Inhibit Myeloid-Derived Suppressor Cells via PI3K/Akt Pathway and Amino Acids Metabolism to Prevent Colitis-Associated Colorectal Cancer.” Journal of Ethnopharmacology, vol. 333, Oct. 2024, p. 118260. EBSCOhost, https://doi.org/10.1016/j.jep.2024.118260.

APA

Lu, Z.-H., Ding, Y., Wang, Y.-J., Chen, C., Yao, X.-R., Yuan, X.-M., Bu, F., Bao, H., Dong, Y.-W., Zhou, Q., Li, L., Chen, T., Li, Y., Zhou, J.-Y., Wang, Q., Shi, G.-P., Jiang, F., & Chen, Y.-G. (2024). Early administration of Wumei Wan inhibit myeloid-derived suppressor cells via PI3K/Akt pathway and amino acids metabolism to prevent colitis-associated colorectal cancer. Journal of Ethnopharmacology, 333, 118260. https://doi.org/10.1016/j.jep.2024.118260

Chicago

Lu, Zhi-Hua, Yang Ding, Yu-Ji Wang, Chen Chen, Xing-Ran Yao, Xiao-Min Yuan, Fan Bu, et al. 2024. “Early Administration of Wumei Wan Inhibit Myeloid-Derived Suppressor Cells via PI3K/Akt Pathway and Amino Acids Metabolism to Prevent Colitis-Associated Colorectal Cancer.” Journal of Ethnopharmacology 333 (October): 118260. doi:10.1016/j.jep.2024.118260.